Gardasil Approved to Prevent Anal Cancer
In the U.S. more than 5,000 people are diagnosed with anal cancer each year. More women than men are diagnosed with it, and people living with HIV experience higher rates of the cancer, especially gay and bisexual men who have had anal sex. Treatment is challenging and can include surgery, radiation or chemotherapy.
The Gardisil vaccine is currently used to prevent certain diseases caused by the human papillomavirus (HPV) in women, such as genital warts, abnormal skin cells of the cervix and cervical cancer. With this recent change, the vaccine has now been approved by the FDA to prevent abnormal skin cells of the anus and anal cancer in men and women. This applies to people 9-26 years of age before sexual activity has started.View Full Article
Visit Project Inform's website to find out more about their activities, publications and services.
Add Your Comment:
(Please note: Your name and comment will be public, and may even show up in
Internet search results. Be careful when providing personal information! Before
adding your comment, please read TheBody.com's Comment Policy.)